Meditation
Behavioral practice · low physical risk · no evidence it treats mitochondrial disease
Proposed mitochondrial link
Meditation may downshift HPA-axis stress signaling, rebalance autonomic activity and reduce NF-κB–linked inflammation. Cortisol findings are inconsistent. Black and Slavich’s 2016 review found RCT signals for lower CRP and IL-6; that supports an anti-inflammatory pathway, not a direct mitochondrial effect.
Strongest direct lead
Bhasin et al. (2013) found relaxation-response practice altered blood gene-expression networks involved in energy metabolism, mitochondrial function and ATP synthase. This is transcriptomic evidence—not proof of more ATP, improved respiration or mitochondrial biogenesis. No human RCT has measured those endpoints after meditation.
Retreat findings, read narrowly
The observational Shamatha Project found about one-third higher white-blood-cell telomerase activity after a three-month retreat, not longer telomeres. A 2025 Dispenza/UC San Diego study followed 20 people before and after a seven-day retreat with no control group. Post-retreat plasma increased neurite growth and glycolytic metabolism in cultured neurons, with no increase in mitochondrial ATP production. The paper was corrected in July 2026 to emphasize its observational design.
Notable voice · Joe Dispenza
Joe Dispenza, D.C., is a chiropractor—not an MD or PhD—bestselling author and CEO of Encephalon, Inc., which sells the retreats studied; he was a co-author. He wrote that “consciousness doesn't reflect our biology – consciousness informs it” and called the physiological evidence “undeniable.” That characterization is his, not the literature’s. Podcast claims that meditator blood “activates mitochondria in cancer cells” exceed the published paper, which contains no cancer-cell mitochondrial experiment.
What is missing
No randomized human trial shows meditation improves mitochondrial respiration, ATP output, mtDNA copy number or biogenesis. No evidence shows it treats mitochondrial disease. The strongest benefits remain stress, anxiety and inflammatory-marker outcomes; mitochondrial protection is plausible and indirect.
Risks, regulation + conflicts
Meditation is generally safe, but anxiety, dissociation and resurfacing trauma can occur; intensive retreats add hyperventilation and emotional-overwhelm risk. Delaying conventional care is the larger danger. Retreats cost thousands. Meditation needs no FDA clearance, but disease-healing claims used to sell retreats sit in FTC/FDA enforcement territory.